OBJECTIVE: To identify clusters of patients with post-traumatic stress disorder (PTSD) according to symptom profile and to examine the association of the A1 allele of the D2 dopamine receptor (DRD2) gene with these clusters. METHOD: Fifty-seven untreated Caucasian Vietnam veterans with PTSD were administered the General Health Questionnaire-28 (GHQ) and the Mississippi Scale for combat-related PTSD. DRD2 allelic status was determined by PCR. RESULTS: Subjects with the DRD2 Al allele compared to those without this allele had significantly higher scores on GHQ 2 (anxiety/insomnia), GHQ 3 (social dysfunction) and GHQ 4 (depression). Cluster analysis of the GHQ data identified two primary groups. A high psychopathology cluster (cluster 3), featured by high co-morbid levels of somatic concerns, anxiety/insomnia, social dysfunction and depression, and a low psychopathology cluster (cluster 1), manifested by the reverse pattern. Scores in each of the four GHQ groups were significantly higher in cluster 3 than cluster 1, as was Mississippi Scale PTSD score. DRD2 A1 allele veterans compared to those without this allele were significantly more likely to be found in the high than the low psychopathology cluster group. CONCLUSIONS: DRD2 variants are associated with severe co-morbid psychopathology in PTSD subjects.
OBJECTIVE: To identify clusters of patients with post-traumatic stress disorder (PTSD) according to symptom profile and to examine the association of the A1 allele of the D2 dopamine receptor (DRD2) gene with these clusters. METHOD: Fifty-seven untreated Caucasian Vietnam veterans with PTSD were administered the General Health Questionnaire-28 (GHQ) and the Mississippi Scale for combat-related PTSD. DRD2 allelic status was determined by PCR. RESULTS: Subjects with the DRD2 Al allele compared to those without this allele had significantly higher scores on GHQ 2 (anxiety/insomnia), GHQ 3 (social dysfunction) and GHQ 4 (depression). Cluster analysis of the GHQ data identified two primary groups. A high psychopathology cluster (cluster 3), featured by high co-morbid levels of somatic concerns, anxiety/insomnia, social dysfunction and depression, and a low psychopathology cluster (cluster 1), manifested by the reverse pattern. Scores in each of the four GHQ groups were significantly higher in cluster 3 than cluster 1, as was Mississippi Scale PTSD score. DRD2 A1 allele veterans compared to those without this allele were significantly more likely to be found in the high than the low psychopathology cluster group. CONCLUSIONS:DRD2 variants are associated with severe co-morbid psychopathology in PTSD subjects.
Authors: A Meyer; D N Klein; D C Torpey; A J Kujawa; E P Hayden; H I Sheikh; S M Singh; G Hajcak Journal: Genes Brain Behav Date: 2012-06-28 Impact factor: 3.449
Authors: Elizabeth P Hayden; Daniel N Klein; Lea R Dougherty; Thomas M Olino; Rebecca S Laptook; Margaret W Dyson; Sara J Bufferd; C Emily Durbin; Haroon I Sheikh; Shiva M Singh Journal: Psychiatr Genet Date: 2010-12 Impact factor: 2.458
Authors: Stephanie E Sillivan; Nadine F Joseph; Sarah Jamieson; Michelle L King; Itzamarie Chévere-Torres; Illeana Fuentes; Gleb P Shumyatsky; Alicia F Brantley; Gavin Rumbaugh; Courtney A Miller Journal: Biol Psychiatry Date: 2017-07-08 Impact factor: 13.382
Authors: Juan R Ordoñana; Meike Bartels; Dorret I Boomsma; David Cella; Miriam Mosing; Joao R Oliveira; Donald L Patrick; Ruut Veenhoven; Gert G Wagner; Mirjam A G Sprangers Journal: Qual Life Res Date: 2012-10-10 Impact factor: 4.147
Authors: Amanda L-C Chen; Thomas J H Chen; Roger L Waite; Jeffrey Reinking; Howard L Tung; Patrick Rhoades; B William Downs; Eric Braverman; Dasha Braverman; Mallory Kerner; Seth H Blum; Nicholas DiNubile; David Smith; Marlene Oscar-Berman; Thomas J Prihoda; John B Floyd; David O'Brien; H H Liu; Kenneth Blum Journal: Med Hypotheses Date: 2008-10-31 Impact factor: 1.538